National Council for Prescription Drug Programs indexing - billing unit
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2013-02-13
- Label type
- Indexing - Billing Unit
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-05 03:24:43
Label at a glance#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 12496-1212-3 | EA - Each | 12496-1212 | e2501033-98ae-4ccb-a8fb-a4432a7646b2 | 1 | 2013-02-13 |
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 12496-1212 | 12496-1212-3 |
Source Document#
Orange Book application contexts#
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N022410-001 | SUBOXONE | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE | EQ 2MG BASE;EQ 0.5MG BASE | FILM / BUCCAL, SUBLINGUAL | AB | RLD | 2010-08-30 |
| N022410-002 | SUBOXONE | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE | EQ 8MG BASE;EQ 2MG BASE | FILM / BUCCAL, SUBLINGUAL | AB | RLD | 2010-08-30 |
| N022410-003 | SUBOXONE | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE | EQ 4MG BASE;EQ 1MG BASE | FILM / BUCCAL, SUBLINGUAL | AB | RLD | 2012-08-10 |
| N022410-004 | SUBOXONE | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE | EQ 12MG BASE;EQ 3MG BASE | FILM / BUCCAL, SUBLINGUAL | AB | RLD, RS | 2012-08-10 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N022410-001 | AB |
| N022410-002 | AB |
| N022410-003 | AB |
| N022410-004 | AB |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N022410-001 | 11135216 | 2029-08-07 | U-3111 | Drug product | 2021-10-21 |
| N022410-001 | 9687454 | 2029-08-07 | U-1464 | Drug product | 2017-07-14 |
| N022410-001 | 8475832 | 2030-03-26 | U-1411 | Drug product | 2013-07-03 |
| N022410-002 | 11135216 | 2029-08-07 | U-3111 | Drug product | 2021-10-21 |
| N022410-002 | 9687454 | 2029-08-07 | U-1464 | Drug product | 2017-07-14 |
| N022410-002 | 8475832 | 2030-03-26 | U-1411 | Drug product | |
| N022410-003 | 11135216 | 2029-08-07 | U-3111 | Drug product | 2021-10-21 |
| N022410-003 | 9687454 | 2029-08-07 | U-1464 | Drug product | 2017-07-14 |
| N022410-003 | 8475832 | 2030-03-26 | U-1411 | Drug product | |
| N022410-004 | 11135216 | 2029-08-07 | U-3111 | Drug product | 2021-10-21 |
| N022410-004 | 9687454 | 2029-08-07 | U-1464 | Drug product | 2017-07-14 |
| N022410-004 | 8475832 | 2030-03-26 | U-1411 | Drug product |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N022410-001 | SUBOXONE | EQ 2MG BASE;EQ 0.5MG BASE | FILM / BUCCAL, SUBLINGUAL | AB | RLD | 2010-08-30 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N022410-002 | SUBOXONE | EQ 8MG BASE;EQ 2MG BASE | FILM / BUCCAL, SUBLINGUAL | AB | RLD | 2010-08-30 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N022410-003 | SUBOXONE | EQ 4MG BASE;EQ 1MG BASE | FILM / BUCCAL, SUBLINGUAL | AB | RLD | 2012-08-10 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N022410-004 | SUBOXONE | EQ 12MG BASE;EQ 3MG BASE | FILM / BUCCAL, SUBLINGUAL | AB | RLD, RS | 2012-08-10 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N022410-001 | SUBOXONE | EQ 2MG BASE;EQ 0.5MG BASE | FILM / BUCCAL, SUBLINGUAL | AB | RLD | 2010-08-30 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N022410-002 | SUBOXONE | EQ 8MG BASE;EQ 2MG BASE | FILM / BUCCAL, SUBLINGUAL | AB | RLD | 2010-08-30 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N022410-003 | SUBOXONE | EQ 4MG BASE;EQ 1MG BASE | FILM / BUCCAL, SUBLINGUAL | AB | RLD | 2012-08-10 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N022410-004 | SUBOXONE | EQ 12MG BASE;EQ 3MG BASE | FILM / BUCCAL, SUBLINGUAL | AB | RLD, RS | 2012-08-10 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N022410-001 | SUBOXONE | EQ 2MG BASE;EQ 0.5MG BASE | FILM / BUCCAL, SUBLINGUAL | AB | RLD | 2010-08-30 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N022410-002 | SUBOXONE | EQ 8MG BASE;EQ 2MG BASE | FILM / BUCCAL, SUBLINGUAL | AB | RLD | 2010-08-30 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N022410-003 | SUBOXONE | EQ 4MG BASE;EQ 1MG BASE | FILM / BUCCAL, SUBLINGUAL | AB | RLD | 2012-08-10 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N022410-004 | SUBOXONE | EQ 12MG BASE;EQ 3MG BASE | FILM / BUCCAL, SUBLINGUAL | AB | RLD, RS | 2012-08-10 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022410-001 | SUBOXONE | EQ 2MG BASE;EQ 0.5MG BASE | FILM / BUCCAL, SUBLINGUAL | AB | RLD | 2010-08-30 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022410-002 | SUBOXONE | EQ 8MG BASE;EQ 2MG BASE | FILM / BUCCAL, SUBLINGUAL | AB | RLD | 2010-08-30 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022410-003 | SUBOXONE | EQ 4MG BASE;EQ 1MG BASE | FILM / BUCCAL, SUBLINGUAL | AB | RLD | 2012-08-10 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022410-004 | SUBOXONE | EQ 12MG BASE;EQ 3MG BASE | FILM / BUCCAL, SUBLINGUAL | AB | RLD, RS | 2012-08-10 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N022410-001 | SUBOXONE | EQ 2MG BASE;EQ 0.5MG BASE | FILM / BUCCAL, SUBLINGUAL | AB | RLD | 2010-08-30 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N022410-002 | SUBOXONE | EQ 8MG BASE;EQ 2MG BASE | FILM / BUCCAL, SUBLINGUAL | AB | RLD | 2010-08-30 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N022410-003 | SUBOXONE | EQ 4MG BASE;EQ 1MG BASE | FILM / BUCCAL, SUBLINGUAL | AB | RLD | 2012-08-10 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N022410-004 | SUBOXONE | EQ 12MG BASE;EQ 3MG BASE | FILM / BUCCAL, SUBLINGUAL | AB | RLD, RS | 2012-08-10 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022410-001 | SUBOXONE | EQ 2MG BASE;EQ 0.5MG BASE | FILM / BUCCAL, SUBLINGUAL | AB | RLD | 2010-08-30 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022410-002 | SUBOXONE | EQ 8MG BASE;EQ 2MG BASE | FILM / BUCCAL, SUBLINGUAL | AB | RLD | 2010-08-30 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022410-003 | SUBOXONE | EQ 4MG BASE;EQ 1MG BASE | FILM / BUCCAL, SUBLINGUAL | AB | RLD | 2012-08-10 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022410-004 | SUBOXONE | EQ 12MG BASE;EQ 3MG BASE | FILM / BUCCAL, SUBLINGUAL | AB | RLD, RS | 2012-08-10 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022410-001 | SUBOXONE | EQ 2MG BASE;EQ 0.5MG BASE | FILM / BUCCAL, SUBLINGUAL | AB | RLD | 2010-08-30 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022410-002 | SUBOXONE | EQ 8MG BASE;EQ 2MG BASE | FILM / BUCCAL, SUBLINGUAL | AB | RLD | 2010-08-30 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022410-003 | SUBOXONE | EQ 4MG BASE;EQ 1MG BASE | FILM / BUCCAL, SUBLINGUAL | AB | RLD | 2012-08-10 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022410-004 | SUBOXONE | EQ 12MG BASE;EQ 3MG BASE | FILM / BUCCAL, SUBLINGUAL | AB | RLD, RS | 2012-08-10 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022410-001 | SUBOXONE | EQ 2MG BASE;EQ 0.5MG BASE | FILM / BUCCAL, SUBLINGUAL | AB | RLD | 2010-08-30 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022410-002 | SUBOXONE | EQ 8MG BASE;EQ 2MG BASE | FILM / BUCCAL, SUBLINGUAL | AB | RLD | 2010-08-30 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022410-003 | SUBOXONE | EQ 4MG BASE;EQ 1MG BASE | FILM / BUCCAL, SUBLINGUAL | AB | RLD | 2012-08-10 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022410-004 | SUBOXONE | EQ 12MG BASE;EQ 3MG BASE | FILM / BUCCAL, SUBLINGUAL | AB | RLD, RS | 2012-08-10 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022410-001 | SUBOXONE | EQ 2MG BASE;EQ 0.5MG BASE | FILM / BUCCAL, SUBLINGUAL | AB | RLD | 2010-08-30 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022410-002 | SUBOXONE | EQ 8MG BASE;EQ 2MG BASE | FILM / BUCCAL, SUBLINGUAL | AB | RLD | 2010-08-30 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022410-003 | SUBOXONE | EQ 4MG BASE;EQ 1MG BASE | FILM / BUCCAL, SUBLINGUAL | AB | RLD | 2012-08-10 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022410-004 | SUBOXONE | EQ 12MG BASE;EQ 3MG BASE | FILM / BUCCAL, SUBLINGUAL | AB | RLD, RS | 2012-08-10 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022410-001 | SUBOXONE | EQ 2MG BASE;EQ 0.5MG BASE | FILM / BUCCAL, SUBLINGUAL | AB | RLD | 2010-08-30 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022410-002 | SUBOXONE | EQ 8MG BASE;EQ 2MG BASE | FILM / BUCCAL, SUBLINGUAL | AB | RLD | 2010-08-30 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022410-003 | SUBOXONE | EQ 4MG BASE;EQ 1MG BASE | FILM / BUCCAL, SUBLINGUAL | AB | RLD | 2012-08-10 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022410-004 | SUBOXONE | EQ 12MG BASE;EQ 3MG BASE | FILM / BUCCAL, SUBLINGUAL | AB | RLD, RS | 2012-08-10 | 5bbf6a4d5a75… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N022410-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N022410-002 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N022410-003 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N022410-004 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N022410-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N022410-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N022410-003 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N022410-004 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N022410-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N022410-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N022410-003 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N022410-004 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022410-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022410-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022410-003 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022410-004 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N022410-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N022410-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N022410-003 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N022410-004 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022410-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022410-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022410-003 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022410-004 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022410-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022410-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022410-003 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022410-004 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022410-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022410-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022410-003 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022410-004 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022410-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022410-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022410-003 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022410-004 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022410-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022410-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022410-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022410-004 | AB | 1 | 5bbf6a4d5a75… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N022410-001 | 11135216 | 2029-08-07 | U-3111 | Drug product | 2021-10-21 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N022410-001 | 9687454 | 2029-08-07 | U-1464 | Drug product | 2017-07-14 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N022410-001 | 8475832 | 2030-03-26 | U-1411 | Drug product | 2013-07-03 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N022410-002 | 11135216 | 2029-08-07 | U-3111 | Drug product | 2021-10-21 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N022410-002 | 9687454 | 2029-08-07 | U-1464 | Drug product | 2017-07-14 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N022410-002 | 8475832 | 2030-03-26 | U-1411 | Drug product | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N022410-003 | 11135216 | 2029-08-07 | U-3111 | Drug product | 2021-10-21 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N022410-003 | 9687454 | 2029-08-07 | U-1464 | Drug product | 2017-07-14 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N022410-003 | 8475832 | 2030-03-26 | U-1411 | Drug product | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N022410-004 | 11135216 | 2029-08-07 | U-3111 | Drug product | 2021-10-21 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N022410-004 | 9687454 | 2029-08-07 | U-1464 | Drug product | 2017-07-14 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N022410-004 | 8475832 | 2030-03-26 | U-1411 | Drug product | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N022410-001 | 11135216 | 2029-08-07 | U-3111 | Drug product | 2021-10-21 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N022410-001 | 9687454 | 2029-08-07 | U-1464 | Drug product | 2017-07-14 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N022410-001 | 8475832 | 2030-03-26 | U-1411 | Drug product | 2013-07-03 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N022410-002 | 11135216 | 2029-08-07 | U-3111 | Drug product | 2021-10-21 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N022410-002 | 9687454 | 2029-08-07 | U-1464 | Drug product | 2017-07-14 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N022410-002 | 8475832 | 2030-03-26 | U-1411 | Drug product | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022410-003 | 11135216 | 2029-08-07 | U-3111 | Drug product | 2021-10-21 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N022410-003 | 9687454 | 2029-08-07 | U-1464 | Drug product | 2017-07-14 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N022410-003 | 8475832 | 2030-03-26 | U-1411 | Drug product | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022410-004 | 11135216 | 2029-08-07 | U-3111 | Drug product | 2021-10-21 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N022410-004 | 9687454 | 2029-08-07 | U-1464 | Drug product | 2017-07-14 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N022410-004 | 8475832 | 2030-03-26 | U-1411 | Drug product | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022410-001 | 11135216 | 2029-08-07 | U-3111 | Drug product | 2021-10-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N022410-001 | 9687454 | 2029-08-07 | U-1464 | Drug product | 2017-07-14 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N022410-001 | 8475832 | 2030-03-26 | U-1411 | Drug product | 2013-07-03 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N022410-002 | 11135216 | 2029-08-07 | U-3111 | Drug product | 2021-10-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N022410-002 | 9687454 | 2029-08-07 | U-1464 | Drug product | 2017-07-14 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N022410-002 | 8475832 | 2030-03-26 | U-1411 | Drug product | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022410-003 | 11135216 | 2029-08-07 | U-3111 | Drug product | 2021-10-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N022410-003 | 9687454 | 2029-08-07 | U-1464 | Drug product | 2017-07-14 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N022410-003 | 8475832 | 2030-03-26 | U-1411 | Drug product | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022410-004 | 11135216 | 2029-08-07 | U-3111 | Drug product | 2021-10-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N022410-004 | 9687454 | 2029-08-07 | U-1464 | Drug product | 2017-07-14 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N022410-004 | 8475832 | 2030-03-26 | U-1411 | Drug product | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022410-001 | 11135216 | 2029-08-07 | U-3111 | Drug product | 2021-10-21 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022410-001 | 9687454 | 2029-08-07 | U-1464 | Drug product | 2017-07-14 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022410-001 | 8475832 | 2030-03-26 | U-1411 | Drug product | 2013-07-03 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022410-002 | 11135216 | 2029-08-07 | U-3111 | Drug product | 2021-10-21 | 31067a03dcf5… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Suboxone | BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE | INDIVIOR INC. | 8a5edcf9-828c-4f97-b671-268ab13a8ecd | 2025-12-22 | Warnings, Adverse reactions | 12496-1212-3 12496121203 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.